


Industry & Biotech
2024-05-13 ~ 2024-05-17
In town for PEGS Boston by the Cambridge Healthtech Institute? Make sure to attend our luncheon presentation:

Mingkun Zhang, Director, NeoMab™ Platform, GemPharmatech
Antibodies and their derivatives have proven significant effectiveness against human diseases, but challenges like immunogenicity and engineering failures hinder their progress. GemPharmatech's platform, based on humanized transgenic animal models, addresses these issues, and enable the efficient development of therapeutic antibodies. This presentation will share the development and validation of these models, as well as case studies for antibody discovery.


This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
Let us know which event you're attending and we'd be happy to connect with you.
